@inproceedings{inproceedings, title = {{CONFIRM: A phase III randomized trial to evaluate the efficacy of nivolumab versus placebo in relapsed mesothelioma.}}, publisher = {{American Society of Clinical Oncology (ASCO)}}, url = {{}}, year = {{2018}}, month = {{5}}, author = {{Fennell DA and Kirkpatrick EV and Cozens K and Danson S and Hanna GG and Lester JF and Lord J and Nye M and Ottensmeier CHH and Szlosarek PW and Steele NL et al}}, doi = {{10.1200/jco.2018.36.15_suppl.tps8586}}, volume = {{36}}, journal = {{Journal of Clinical Oncology}}, issue = {{15_suppl}}, pages = {{TPS8586-TPS8586}}, note = {{Accessed on 2025/05/28}}}